ArticlePharmaceutics2024

A Novel Lactose/MCC/L-HPC Triple-Based Co-Processed Excipients with Improved Tableting Performance Designed for Metoclopramide Orally Disintegrating Tablets.

Xiaorong Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.